Navigation Links
CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
Date:11/3/2008

g the risk that CuraGen's pursuit of partnership opportunities will not proceed as planned or that any one or more of CuraGen's drug development programs will not proceed as planned for technical, scientific or commercial reasons or due to patient enrollment issues or based on new information from nonclinical or clinical studies or from other sources, as well as risk associated with the success of competing products and technologies, CuraGen's stage of development as a biopharmaceutical company, government regulation and healthcare reform, technological uncertainty and product development risks, product liability exposure, uncertainty of additional funding, CuraGen's ability to comply with Nasdaq listing requirements, CuraGen's history of incurring losses and the uncertainty of achieving profitability, reliance on research collaborations and strategic alliances, competition, patent infringement claims against CuraGen's products, processes and technologies, CuraGen's ability to protect its patents and proprietary rights and uncertainties relating to commercialization rights, as well as those risks, uncertainties and factors referred to under the section "Risk Factors" in CuraGen's Quarterly Report on Form 10-Q for the quarter ended June 30, 2008, filed with the Securities and Exchange Commission as well as other documents that may be filed by CuraGen from time to time with the Securities and Exchange Commission. As a result of such risks, uncertainties and factors, CuraGen's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. CuraGen is providing the information in this press release as of this date and assumes no obligations to update the information included in this press release or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CRGN-P

Contacts:

Sean Cassidy

Vic
'/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
10. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
11. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced ... and by Application - Forecast to 2020" report to their ... reach $13.1 Billion in 2020 from an estimated $7.1 Billion in ... is dominated by North America , followed by ... Rest of the World (RoW). The cancer diagnostics market in ...
(Date:7/2/2015)... 2015 Numotion,s Board of Directors and ... Tamas Feitel has joined the Company as Chief ... highly successful 18 year career at GE serving in ... and productivity to result in significant industry leading growth ... Financial Officer for GE Healthcare Global Services, a $5B ...
(Date:7/2/2015)... N.C. , July 2, 2015 ... assets related to the ion channel biology platform from ... been obtained as part of Pfizer,s 2011 acquisition of ... rights to the "Icagen" name and trademark.  XRPro Sciences ... services for ion channel and transporter drug discovery, combining ...
Breaking Medicine Technology:Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Numotion Names Tamas Feitel Chief Financial Officer 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
... Many of this country,s 80 million Baby Boomers(1) who ... hypertension and even depression, are not aware that some ... from something they didn,t bargain for...occasional constipation. ... nationwide survey of 1,150 men and women age 50 ...
... Oct. 19, 2011 As the rate of teen prescription ... National Association of School Nurses (NASN) and Janssen Pharmaceuticals, Inc., ... a new tool kit intended to help America,s schools educate ... abusing prescription medication . To view ...
Cached Medicine Technology:Adding "Insult to Injury" - Occasional Constipation Can Be a Troubling Side Effect for Baby Boomers Taking Medication for Pain, Heartburn, Depression and More 2Adding "Insult to Injury" - Occasional Constipation Can Be a Troubling Side Effect for Baby Boomers Taking Medication for Pain, Heartburn, Depression and More 3Adding "Insult to Injury" - Occasional Constipation Can Be a Troubling Side Effect for Baby Boomers Taking Medication for Pain, Heartburn, Depression and More 4Dr. Drew Pinsky Joins National Association of School Nurses to Launch School Tool Kit Addressing Teen Prescription Drug Abuse 2Dr. Drew Pinsky Joins National Association of School Nurses to Launch School Tool Kit Addressing Teen Prescription Drug Abuse 3Dr. Drew Pinsky Joins National Association of School Nurses to Launch School Tool Kit Addressing Teen Prescription Drug Abuse 4
(Date:7/3/2015)... Deer, Alberta (PRWEB) , ... July 03, 2015 , ... ... host their 24-Hour Train-a-Thon where they provide members of the Red Deer community with ... year’s full day of fitness training, games, food, events and entertainment raised thousands of ...
(Date:7/2/2015)... ... ... pleased to announce the opening of its newest location in Dallas, Texas. The opening is ... chain was listed as #22 on the Inc. 500 list of fastest growing companies in ... located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , “We are excited ...
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association of Poison ... Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with ... to decrease drug overdose – especially of heroin and opioid medication – by ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... With summer in full swing, Americans are ... is one of the top spots for fishing in the world, and it’s easy to ... of Ontario, Canada has great fish. , Recreational fishing is a huge industry, and ...
(Date:7/2/2015)... ... ... As Americans celebrate the Fourth of July outdoors this weekend, local physicians are ... is UV Safety Month, and physicians at American Family Care and AFC Doctors Express ... say most skin cancers can be found early with regular skin exams. Physicians can ...
Breaking Medicine News(10 mins):Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... ... ... ... ...
... March issue of the Journal of Thoracic Oncology ... and efficacy between patients age 70 and over and ... salvage targeted therapy with epidermal growth factor receptor-tyrosine kinase ... leading cause of cancer death in the world. Lung ...
... Scientists are beginning to find out why people with ... it harder to recognize expressions of emotion in other ... the American Psychological Association. One of the studies ... available treatment for patients who no longer respond to ...
... According to a ... has not decreased their defensive medicine practices. , ... Alpharetta, GA (Vocus) March 2, 2010 -- According to a recent ... tort reform has not decreased their defensive medicine practices., , ,Texas enacted tort reform measures ...
... ... , ... AZ (PRWEB) March 3, 2010 -- NightHawk Radiology Services, the leading provider of ... new physician leaders to its Medical Executive Team (MET), an influential group of affiliated ...
... ... ... , ... , , ...
Cached Medicine News:Health News:Seattle Sutton's Healthy Eating Sponsoring The Biggest Loser Chicago Casting Call 2Health News:Seattle Sutton's Healthy Eating Sponsoring The Biggest Loser Chicago Casting Call 3Health News:Seattle Sutton's Healthy Eating Sponsoring The Biggest Loser Chicago Casting Call 4Health News:Patient age not a factor in use of second-line therapy for lung cancer 2Health News:Parkinson's disease makes it harder to figure out how other people feel 2Health News:Parkinson's disease makes it harder to figure out how other people feel 3Health News:Tort Reform Does Not Eliminate Defensive Medicine Practices, Study Finds 2Health News:Tort Reform Does Not Eliminate Defensive Medicine Practices, Study Finds 3Health News:NightHawk Radiology Services Expands Its Medical Executive Team 2Health News:NightHawk Radiology Services Expands Its Medical Executive Team 3Health News:Kidney Patients From Across South Carolina Visit State Capitol to Encourage Policies that Improve Patient Access to Life-Saving Dialysis and Transplant Care 2Health News:Kidney Patients From Across South Carolina Visit State Capitol to Encourage Policies that Improve Patient Access to Life-Saving Dialysis and Transplant Care 3Health News:Kidney Patients From Across South Carolina Visit State Capitol to Encourage Policies that Improve Patient Access to Life-Saving Dialysis and Transplant Care 4Health News:Kidney Patients From Across South Carolina Visit State Capitol to Encourage Policies that Improve Patient Access to Life-Saving Dialysis and Transplant Care 5Health News:Kidney Patients From Across South Carolina Visit State Capitol to Encourage Policies that Improve Patient Access to Life-Saving Dialysis and Transplant Care 6